EcoR1 Capital’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

EcoR1 Capital’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-462,068	Closed	-$1.25M	–	63
2018 Q3	$1.25M	Buy	462,068 +50,068	+12%	+$104K	0.11%	47
2018 Q2	$787K	Buy	+412,000	New	+$832K	0.07%	33

Other funds holding INFI

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $203M AUM 34.78% 1-Year Est. Return

EcoR1 Capital's INFI Position: Q4 2018 in Review

EcoR1 Capital sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2018, closing a stake of 462,068 shares — an estimated $1.25M sold.

EcoR1 Capital first reported a position in INFI in Q2 2018 and held it in 2 quarters. The position peaked at $1.25M in Q3 2018. 64 funds tracked by Wall St. Rank hold INFI as of Q4 2018.

EcoR1 Capital reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2018 after selling out during the quarter.
EcoR1 Capital sold 462,068 Infinity Pharmaceuticals, Inc. shares in Q4 2018, an estimated $1.25M.
EcoR1 Capital first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2018 and held it in 2 quarters.
EcoR1 Capital's Infinity Pharmaceuticals, Inc. position peaked at $1.25M in Q3 2018.
64 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2018.

Based on EcoR1 Capital's 13F filing for Q4 2018, filed 14 Feb 2019.